Skip Ribbon Commands
Skip to main content
Menu
Assoc Prof Ong Chin-Ann Johnny

Assoc Prof Ong Chin-Ann Johnny

MBBS (S'pore), MRCS (Ed), M Med (Surgery), FRCS (Ed), PhD (Cambridge)

Senior Consultant

National Cancer Centre Singapore

Specialty/Department: Surgery & Surgical Oncology, Sarcoma, Peritoneal and Rare Tumours (SPRinT)

Clinical Interest: Peritoneal-based Malignancies, Sarcoma, Skin & Melanoma, Colorectal, Gastrointestinal, Gastrointestinal Oncology, General Surgery, Gynae-Oncology, Lymphoma (DMO, DRO), Melanoma, Pelvic & Peritoneal, Sarcoma/Skin, Supportive & Palliative Care, Upper Gastrointestinal

Conditions Treated by this Doctor:
Anal Cancers, Colorectal Cancer, Gastrointestinal Stromal Tumour (GIST), Lymphoma, Melanoma, Ovarian Cancer, Peritoneal Cancer (Peritoneal Surface Malignancies), Sarcoma, Skin Cancer, Stomach Cancer.

Clinical Appointments

  • Senior Consultant Division of Surgery & Surgical Oncology National Cancer Centre SingaporeNational Cancer Centre Singapore
  • Senior Consultant Sarcoma, Peritoneal and Rare Tumours (SPRinT) Singapore General HospitalSingapore General Hospital
  • Visiting Consultant KK Women's and Children's HospitalKK Women's and Children's Hospital

Academic Appointments

  • Clinical Tutor, Yong Loo Lin School of Medicine
  • Adjunct Teaching Faculty member, Lee Kong Chian School of Medicine
  • Principal Investigator, Laboratory of Applied Human Genetics, National Cancer Centre Singapore
  • Clinical Core Faculty Member (CCFM), SingHealth Surgery Residency Programme
  • Associate Professor, Duke-NUS Graduate Medical School

Profile

Dr Johnny Ong is a Senior Consultant in the Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore. He is also theView More +

Education

  • Royal College of Surgeons (Edinburgh), FRCS, 2016
  • National University of Singapore (Yong Loo Lin School of Medicine), Master of Medicine, 2016
  • University of Cambridge (Oncology), PhD, 2013
  • Royal College of Surgeons (Edinburgh), MRCS, 2008
  • National University of Singapore (Yong Loo Lin School of Medicine), MBBS, 2004

Professional Appointments and Committee Memberships

  • Member, FY2022 SingHealth Foundation Talent Development Fund (TDF) & Ministry of Health In-Service Scholarship (MOH-ISS) Research Interview Panel
  • Member, Undergraduate Curriculum Committee, Division of Surgery and Surgical Oncology (01/04/2021 – 31/03/2023)
  • Clinical Core Faculty Member (CCFM), SingHealth Surgery Residency Programme (01/07/2020 – 30/07/2023)
  • Joint Research Clinician, Institute of Molecular and Cell Biology (IMCB), A*STAR Research Entites (2020 – 2023)
  • Member, SurgeryACP Research Strategic Workgroup (2020 – Present)
  • Member, Grant Monitoring Panel for NCCS Cancer Fund (Research) (2020 – Present)
  • Programme Director, Surgical Oncology Fellowship Programme, Division of Surgery and Surgical Oncology, NCCS (2019 – Present)
  • Adjunct Teaching Faculty Member, Lee Kong Chian School of Medicine, NTU (2019 – 2023)
  • Head of Research, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, NCCS (2019 – Present)
  • Consultant, Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, NCCS (2019 – Present)
  • Research Mentor, Duke-NUS Medical School (2018 – Present)
  • Assistant Professor, Duke-NUS Medical School (2017 – Present)
  • Principal Investigator, Laboratory of Applied Human Genetics, Division of Medical Sciences, NCCS (2014 – Present)
View More +

Awards

  • NMRC Clinician Scientist-Individual Research Grant, NMRC, 2021
  • Special Recognition Award, Yong Loo Lin School of Medicine, NUS, 2021
  • Outstanding Faculty Award, SingHealth Residency, 2021
  • Special Recognition Award, Yong Loo Lin School of Medicine, NUS, 2020
  • Outstanding Faculty Award, SingHealth Residency, 2020
  • Silver Award, SingHealth Quality Service Awards, 2020
  • Special Recognition Award, Yong Loo Lin School of Medicine, NUS, 2019
  • Health Manpower Development Plan (HMDP) Fellowship, Ministry of Health, 2019
  • Special Recognition Award, Yong Loo Lin School of Medicine, NUS, 2018
  • Khoo Pilot Award (Collaborative), Duke-NUS Medical School, 2018
  • NMRC Transition Award, NMRC, 2017
  • Special Recognition Award, Yong Loo Lin School of Medicine, NUS, 2017
  • Dean's Excellence Award, Yong Loo Lin School of Medicine, NUS, 2017
  • Distinguished Young Researcher Award, SingHealth Excellence Awards, 2016
  • 1st Prize, Young Investigator's Award (Basic/Translational Research), SGH Annual Scientific Meeting 2015, 2015
  • Best Registrar Award, SingHealth, 2015
  • Best Poster prize, British Society of Gastroenterology (Cambridge), 2013
  • Overseas travel grant, United European Gastroenterology Week (UEGW) (Amsterdam), 2012
  • Best Poster prize, Hutchison-MRC Annual Retreat (Cambridge), 2011
  • 3rd prize for oral presentation, 4th National Barrett's Symposium (London), 2010
  • NRF-MOH Overseas Scholarship, Ministry of Health, 2008
  • SingHealth Service with a Heart Award, SingHealth, 2008
  • Best Physical Training Award, Singapore Armed Forces, 2006
  • Dean's List, Yong Loo Lin School of Medicine, 2003
  • Best Trainee, School of Infantry Specialists, 1999
View More +

Research Interests

  • Cancer metastasis
  • Tumour microenvironment
  • Biomarkers
  • Novel therapeutic strategies

Publications

  • Retrospective quality of life study in patients with retroperitoneal sarcoma in an Asian population
Lim HJ*, Ong C-AJ*, Skanthakumar T, Mak LYH, Wasudevan SD, Tan JWS, Chia CS, Tan GHC, Teo MCC

    Health Qual Life Out 2020 (Accepted for publication)
    
JIF: 2.318 , times cited: NA (* Equal contribution)
  • Exosome-templated nanoplasmonics for multiparametric molecular profiling Wu X, Zhao H, Natalia A, Lim CZJ, Ho NRY, Ong C-AJ, Teo MCC, So JBY, Shao HL.
    Science Advances Biophysics 2020
    Top 20% journal, JIF: 11.5, times cited: NA
  • Management of Synchronous Lateral Pelvic Nodal Metastasis in Rectal Cancer in the era of Neoadjuvant Chemoradiation: A Systemic Review
Wong JSM, Tan GHC, Chia CS, Ong C-AJ, Teo MCC

    World J Gastrointest Surg 2020
    JIF: NA, times cited: NA
  • Axillary Lymph Node Dissection in Angiosarcomas of the Breast: An Asian Institutional Perspective.
Ragavan S*, Lim HJ*, Tan JWS, Hendrikson J, Chan JY, Farid M, Chia CS, Tan GHC, Soo KC, Teo MCC, Ong C-AJ**
    Sarcoma 2020
    JIF: NA, times cited: 1
(* Equal contribution, ** Corresponding author)
  • Novel prognostic score for outcomes after cytoreductive surgery and HIPEC for colorectal cancer with metachronous peritoneal carcinomatosis.
Chin KM, Tan GHC, Chia CS, Ong CAJ, Teo M

    ANZ Journal of Surgery 2020

    JIF: 1.605, times cited: NA
  • Primary iliocaval leiomyosarcomas: The path beyond surgery.
Ong CAJ, Smith MJ, Snow HA, et al.

    Eur J Surg Oncol 2020

    JIF: 3.379, times cited: 1
  • An optimised protocol harnessing laser capture microdissection for transcriptomic analysis on matched primary and metastatic colorectal tumours.
Ong CAJ*, Tan QX*, Lim HJ*, Shannon NB, et al.

    Scientific Reports 2020
    
JIF: 4.609 , times cited: NA (* Equal contribution)
  • The importance of synchronicity in the management of colorectal peritoneal metastases with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Wong JSM, Tan GHC, Chia CSC, Ong J, et al.

    World J Surg Onco 2020

    JIF: 1.966, times cited: NA
  • High grade complication associated with poor overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Tan JWS*, Tan GHC*, Ng WY, Ong C-AJ, et al.
    
Int J Clin Oncol 2020

    JIF: 2.503, times cited: 1 (* Equal contribution)
  • Dual-selective magnetic analysis of extracellular vesicle glycans. Wang Z, Sun X, Natalia, A, Tang CSL, Ang CBT, Ong C-AJ, et al.
    
Matter 2020
    JIF: NA, times cited: 4
View More +

Research Trials

  • Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Oxaliplatin in Patients with Peritoneal Carcinomatosis (PIPAC) (NCT03172416) (Ongoing, Study role: Co-I)
  • PIPAC for Peritoneal Metastases (NCT04956068) (Ongoing, Study role: Co-I)
  • Radical resection and HIPEC for recurrent retroperitoneal sarcoma (NCT03792867) (Ongoing, Study role: PI)
  • Prophylactic HIPEC for colorectal cancers at high risk of developing peritoneal metastases (NCT03422432) (Ongoing, Study role: Co-I)